Generare raises €20M to decode the 97% of microbial chemistry

1. 1Screen microbial genomes to identify novel small molecules
2. 2Characterize and validate the functional properties of these molecules
3. 3Apply machine learning and AI to analyze genomic data and predict molecular functions
4. 4Integrate the discovered molecules into drug development pipelines

Biotech and pharmaceutical companies can benefit from Generare's technology, as well as researchers in the field of microbiology and genomics, to discover new molecules for drug development

💡 Generare's technology has the potential to revolutionize drug discovery by tapping into the vast chemical diversity of microbial genomes

💡 Generare raises €20M to unlock microbial chemistry secrets!